Fulcrum

Business & Finance

Fulcrum Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2020 Financial Results

By Laverne J. Tiffany 4 years ago

– Company on track to present data from Phase 2b ReDUX4 trial with losmapimod in